On September 30, 2019 Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, reported that it will present at the following upcoming healthcare conferences in October (Press release, Intellia Therapeutics, SEP 30, 2019, View Source [SID1234539914]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Monday, October 7, 2019
Chardan 3rd Annual Genetic Medicines Conference
Location: New York, NY
Time: 9:00 am ET
Tuesday, October 8, 2019
Jefferies Gene Therapy/Editing Summit
Location: New York, NY
Time: 8:35 am ET
A live webcast of Intellia’s presentations at the Chardan and Jefferies conferences will be accessible through the Events and Presentations page of the Investor Relations section of the company’s website at www.intelliatx.com. To access the webcasts, please log on to the Intellia website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Intellia’s website for approximately 14 days following each conference.